1. Home
  2. PUMP vs AMPH Comparison

PUMP vs AMPH Comparison

Compare PUMP & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProPetro Holding Corp.

PUMP

ProPetro Holding Corp.

HOLD

Current Price

$16.87

Market Cap

1.0B

Sector

Energy

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$18.18

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PUMP
AMPH
Founded
2007
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
971.8M
IPO Year
2017
2005

Fundamental Metrics

Financial Performance
Metric
PUMP
AMPH
Price
$16.87
$18.18
Analyst Decision
Buy
Buy
Analyst Count
7
8
Target Price
$14.14
$28.38
AVG Volume (30 Days)
5.5M
644.5K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
100.76
N/A
EPS
N/A
0.14
Revenue
$1,269,158,000.00
$719,887,000.00
Revenue This Year
N/A
$6.90
Revenue Next Year
$15.61
$4.64
P/E Ratio
N/A
$130.00
Revenue Growth
N/A
N/A
52 Week Low
$4.51
$16.65
52 Week High
$18.50
$31.26

Technical Indicators

Market Signals
Indicator
PUMP
AMPH
Relative Strength Index (RSI) 52.47 40.00
Support Level $14.90 $17.03
Resistance Level N/A $20.08
Average True Range (ATR) 0.89 0.81
MACD -0.04 -0.21
Stochastic Oscillator 50.24 19.16

Price Performance

Historical Comparison
PUMP
AMPH

About PUMP ProPetro Holding Corp.

ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and power generation service.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: